{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:44:54Z","timestamp":1790739894572,"version":"4.1.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372977"],"award-info":[{"award-number":["82372977"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303335"],"award-info":[{"award-number":["82303335"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07765-3","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T05:25:00Z","timestamp":1770441900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Neutrophils in nasopharyngeal carcinoma: from mechanisms to therapeutics"],"prefix":"10.1186","volume":"24","author":[{"given":"Wenlin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongshuai","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"issue":"11","key":"7765_CR1","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/cac2.12218","volume":"41","author":"TLLCY Pei","year":"2021","unstructured":"Pei TLLCY, Ben CC, et al. The Chinese society of clinical oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal Carcinoma[J]. Cancer Commun (London England). 2021;41(11):1195\u2013227.","journal-title":"Cancer Commun (London England)"},{"key":"7765_CR2","doi-asserted-by":"crossref","unstructured":"Janvilisri Tavan. Omics-Based Identification of Biomarkers for Nasopharyngeal Carcinoma[J]. Disease Markers. 2015, 2015: 762128.","DOI":"10.1155\/2015\/762128"},{"key":"7765_CR3","doi-asserted-by":"publisher","first-page":"101117","DOI":"10.1016\/j.currproblcancer.2024.101117","volume":"51","author":"Q Huang Xiaoxian","year":"2024","unstructured":"Huang Xiaoxian Q, Xinling H, Weimei, et al. The predictive value of hematological inflammatory markers for severe oral mucositis in patients with nasopharyngeal carcinoma during Intensity-Modulated radiation therapy: A retrospective cohort Study[J]. Curr Probl Cancer. 2024;51:101117.","journal-title":"Curr Probl Cancer"},{"issue":"11","key":"7765_CR4","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41422-020-0374-x","volume":"30","author":"CY Pei","year":"2020","unstructured":"Pei CY, Hua YJ, Fei LW, et al. Single-Cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal Carcinoma[J]. Cell Res. 2020;30(11):1024\u201342.","journal-title":"Cell Res"},{"key":"7765_CR5","doi-asserted-by":"crossref","unstructured":"Del Ho PE, Lin I, Chiara B, et al. Epithelial memory of inflammation limits tissue damage while promoting pancreatic Tumorigenesis[J]. Volume 373. Science; 2021. p. eabj0486. (New York, N.Y.). 6561.","DOI":"10.1126\/science.abj0486"},{"key":"7765_CR6","doi-asserted-by":"crossref","unstructured":"Zhao W, Li X, Lv L et al. Systematic review and metanalysis of neutrophil to lymphocyte ratio and prognosis in patients with nasopharyngeal Carcinoma[J]. Laryngoscope Invest Otolaryngol, 2023, 8(6).","DOI":"10.1002\/lio2.1161"},{"issue":"8","key":"7765_CR7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nri3024","volume":"11","author":"A Mantovani Alberto, Cassatella Marco","year":"2011","unstructured":"Mantovani Alberto, Cassatella Marco A, Costantini, Claudio, et al. Neutrophils in the activation and regulation of innate and adaptive Immunity[J]. Nat Rev Immunol. 2011;11(8):519\u201331.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"7765_CR8","doi-asserted-by":"publisher","first-page":"188762","DOI":"10.1016\/j.bbcan.2022.188762","volume":"1877","author":"F Que Haiying","year":"2022","unstructured":"Que Haiying F, Qianmei L, Tianxia, et al. Tumor-Associated neutrophils and Neutrophil-Targeted cancer Therapies[J]. Biochim Et Biophys Acta Reviews Cancer. 2022;1877(5):188762.","journal-title":"Biochim Et Biophys Acta Reviews Cancer"},{"issue":"9","key":"7765_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","volume":"20","author":"P Jaillon Sebastien","year":"2020","unstructured":"Jaillon Sebastien P, Di Andrea M, Diletta, et al. Neutrophil diversity and plasticity in tumour progression and Therapy[J]. Nat Rev Cancer. 2020;20(9):485\u2013503.","journal-title":"Nat Rev Cancer"},{"issue":"10445","key":"7765_CR10","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1016\/S0140-6736(24)00594-4","volume":"403","author":"Z Liu Xu","year":"2024","unstructured":"Liu Xu Z, Yuan YK. Induction-Concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): A Multicentre, Open-Label, Parallel-Group, Randomised, Controlled, phase 3 Trial[J]. Lancet (London England). 2024;403(10445):2720\u201331.","journal-title":"Lancet (London England)"},{"issue":"9","key":"7765_CR11","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/s41590-020-0736-z","volume":"21","author":"S Xie Xuemei","year":"2020","unstructured":"Xie Xuemei S, Qiang W, Peng, et al. Single-Cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and Infection[J]. Nat Immunol. 2020;21(9):1119\u201333.","journal-title":"Nat Immunol"},{"key":"7765_CR12","doi-asserted-by":"publisher","first-page":"602963","DOI":"10.3389\/fimmu.2021.602963","volume":"12","author":"MA McKenna Ellen","year":"2021","unstructured":"McKenna Ellen MA, Ui W. Neutrophils: need for standardized Nomenclature[J]. Front Immunol. 2021;12:602963.","journal-title":"Front Immunol"},{"key":"7765_CR13","doi-asserted-by":"publisher","first-page":"1180810","DOI":"10.3389\/fimmu.2023.1180810","volume":"14","author":"C Di Carnevale Silvia","year":"2023","unstructured":"Di Carnevale Silvia C, Irene G, Giovanna, et al. Neutrophil diversity in inflammation and Cancer[J]. Front Immunol. 2023;14:1180810.","journal-title":"Front Immunol"},{"issue":"20","key":"7765_CR14","doi-asserted-by":"publisher","first-page":"7709","DOI":"10.3390\/ijms21207709","volume":"21","author":"W Zhang Yuting","year":"2020","unstructured":"Zhang Yuting W, Emily LX. Human isogenic cell line models for neutrophils and Myeloid-Derived suppressor cells[J]. Int J Mol Sci. 2020;21(20):7709.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7765_CR15","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41467-021-21795-z","volume":"12","author":"KDL Gong Lanqi","year":"2021","unstructured":"Gong Lanqi KDL, Wan D, Wei, et al. Comprehensive Single-Cell sequencing reveals the stromal dynamics and Tumor-Specific characteristics in the microenvironment of nasopharyngeal Carcinoma[J]. Nat Commun. 2021;12(1):1540.","journal-title":"Nat Commun"},{"issue":"1","key":"7765_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/cac2.12613","volume":"45","author":"J Yao Jiali","year":"2025","unstructured":"Yao Jiali J, Linlin W. Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying Mechanisms[J]. Cancer Commun (London England). 2025;45(1):15\u201342.","journal-title":"Cancer Commun (London England)"},{"issue":"11","key":"7765_CR17","doi-asserted-by":"publisher","first-page":"5756","DOI":"10.3390\/cimb44110390","volume":"44","author":"A-S Aviva","year":"2022","unstructured":"Aviva A-S, Hassan A, Ludimila C, et al. Tumor molecular and microenvironment characteristics in EBV-Associated malignancies as potential therapeutic targets: focus on gastric Cancer[J]. Curr Issues Mol Biol. 2022;44(11):5756\u201367.","journal-title":"Curr Issues Mol Biol"},{"key":"7765_CR18","doi-asserted-by":"publisher","first-page":"744889","DOI":"10.3389\/fonc.2021.744889","volume":"11","author":"KDL Gong Lanqi","year":"2021","unstructured":"Gong Lanqi KDL, Wan D, Wei, et al. The stromal and immune landscape of nasopharyngeal carcinoma and its implications for precision medicine targeting the tumor Microenvironment[J]. Front Oncol. 2021;11:744889.","journal-title":"Front Oncol"},{"issue":"3","key":"7765_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","volume":"16","author":"G Fridlender Zvi","year":"2009","unstructured":"Fridlender Zvi G, Sun Jing K, Samuel, et al. Polarization of Tumor-Associated neutrophil phenotype by TGF-Beta: N1 versus N2 TAN[J]. Cancer Cell. 2009;16(3):183\u201394.","journal-title":"Cancer Cell"},{"issue":"11","key":"7765_CR20","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3390\/cells13110963","volume":"13","author":"G Singh Pragya","year":"2024","unstructured":"Singh Pragya G, Manisha AQ, Batool, et al. Flow cytometry as the tool to define peripheral blood leukocyte signatures in acute EBV Infection[J]. Cells. 2024;13(11):963.","journal-title":"Cells"},{"issue":"3","key":"7765_CR21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/QCO.0b013e32833939b0","volume":"23","author":"Nuutila Jari","year":"2010","unstructured":"Nuutila Jari. The novel applications of the quantitative analysis of neutrophil cell surface FcgammaRI (CD64) to the diagnosis of infectious and inflammatory Diseases[J]. Curr Opin Infect Dis. 2010;23(3):268\u201374.","journal-title":"Curr Opin Infect Dis"},{"key":"7765_CR22","doi-asserted-by":"publisher","first-page":"e12638","DOI":"10.1590\/1414-431x2023e12638","volume":"56","author":"CB Yuan Qi","year":"2023","unstructured":"Yuan Qi CB, Hong H, Jia D, et al. Preclinical study of LMP1-RNAi-Based Anti-Tumor therapy in EBV-Positive nasopharyngeal Carcinoma[J]. Brazilian J Med Biol Res = Revista Brasileira De Pesquisas Medicas E Biologica. 2023;56:e12638.","journal-title":"Brazilian J Med Biol Res = Revista Brasileira De Pesquisas Medicas E Biologica"},{"issue":"1","key":"7765_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12967-024-05880-7","volume":"23","author":"Z Wang Huilin","year":"2025","unstructured":"Wang Huilin Z, Yuting L, Jiadi, et al. Unveiling immune resistance mechanisms in nasopharyngeal carcinoma and emerging targets for antitumor immune response: tertiary lymphoid Structures[J]. J Translational Med. 2025;23(1):38.","journal-title":"J Translational Med"},{"key":"7765_CR24","doi-asserted-by":"publisher","first-page":"107129","DOI":"10.1016\/j.oraloncology.2024.107129","volume":"160","author":"L Li Hui","year":"2025","unstructured":"Li Hui L, Liming D, Juan, et al. Multimodal profiling uncovers tertiary lymphoid structures as a critical determinant of immunotherapy response and prognosis in nasopharyngeal Carcinoma[J]. Oral Oncol. 2025;160:107129.","journal-title":"Oral Oncol"},{"key":"7765_CR25","doi-asserted-by":"publisher","first-page":"113944","DOI":"10.1016\/j.intimp.2024.113944","volume":"147","author":"L Huang Zongwei","year":"2025","unstructured":"Huang Zongwei L, Qinying YL, et al. SPP1-Mediated M2 macrophage polarization shapes the tumor microenvironment and enhances prognosis and immunotherapy guidance in nasopharyngeal Carcinoma[J]. Int Immunopharmacol. 2025;147:113944.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"7765_CR26","doi-asserted-by":"publisher","first-page":"104571","DOI":"10.1016\/j.amjoto.2024.104571","volume":"46","author":"LHJJJ Gu","year":"2025","unstructured":"Gu LHJJJ, Yi LP, et al. Systemic immune inflammation index combined with Epstein-Barr virus DNA for predicting the prognosis of nasopharyngeal carcinoma: A retrospective Study[J]. Am J Otolaryngol. 2025;46(1):104571.","journal-title":"Am J Otolaryngol"},{"key":"7765_CR27","doi-asserted-by":"crossref","unstructured":"Zhang Xiaowei Q, Shen\u2019er et al. Wu Ping\u2019an,. Tumor-Associated Macrophage-Derived Itaconic Acid Contributes to Nasopharyngeal Carcinoma Progression by Promoting Immune Escape via TET2[J]. Cell communication and signaling: CCS, 2024, 22(1): 413.","DOI":"10.1186\/s12964-024-01799-0"},{"issue":"10","key":"7765_CR28","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1172\/JCI39065","volume":"119","author":"A Charles Kellie","year":"2009","unstructured":"Charles Kellie A, Kulbe Hagen S, Robin, et al. The Tumor-Promoting actions of TNF-Alpha involve TNFR1 and IL-17 in ovarian cancer in mice and Humans[J]. J Clin Investig. 2009;119(10):3011\u201323.","journal-title":"J Clin Investig"},{"key":"7765_CR29","doi-asserted-by":"publisher","first-page":"1524038","DOI":"10.3389\/fimmu.2025.1524038","volume":"16","author":"J Zhu Meng","year":"2025","unstructured":"Zhu Meng J, Ru Z. The success of the tumor immunotherapy: neutrophils from bench to Beside[J]. Front Immunol. 2025;16:1524038.","journal-title":"Front Immunol"},{"key":"7765_CR30","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3389\/fimmu.2020.01259","volume":"11","author":"A Capucetti Arianna","year":"2020","unstructured":"Capucetti Arianna A, Francesca. Bonecchi Raffaella. Multiple roles for chemokines in neutrophil Biology[J]. Front Immunol. 2020;11:1259.","journal-title":"Front Immunol"},{"issue":"8","key":"7765_CR31","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.it.2010.05.006","volume":"31","author":"M Summers Charlotte, Rankin Sara","year":"2010","unstructured":"Summers Charlotte, Rankin Sara M, Condliffe Alison M, et al. Neutrophil kinetics in health and Disease[J]. Trends Immunol. 2010;31(8):318\u201324.","journal-title":"Trends Immunol"},{"issue":"1","key":"7765_CR32","doi-asserted-by":"publisher","first-page":"1758606","DOI":"10.1080\/2162402X.2020.1758606","volume":"9","author":"F Dadaglio Gilles","year":"2020","unstructured":"Dadaglio Gilles F, Catherine O, Marine, et al. IL-17 suppresses the therapeutic activity of cancer vaccines through the Inhibition of CD8\u2009+\u2009T-Cell Responses[J]. Oncoimmunology. 2020;9(1):1758606.","journal-title":"Oncoimmunology"},{"issue":"6","key":"7765_CR33","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3390\/cells9061400","volume":"9","author":"C M\u00fcnz","year":"2020","unstructured":"M\u00fcnz C. Redirecting T cells against Epstein-Barr virus infection and associated Oncogenesis[J]. Cells. 2020;9(6):1400.","journal-title":"Cells"},{"issue":"1","key":"7765_CR34","first-page":"437","volume":"13","author":"LJ Li Xing","year":"2020","unstructured":"Li Xing LJ, Nan LJ, et al. Accumulation of LOX-1\u2009+\u2009PMN-MDSCs in nasopharyngeal carcinoma survivors with chronic hepatitis B might permit immune tolerance to Epstein-Barr virus and relate to tumor Recurrence[J]. Aging. 2020;13(1):437\u201349.","journal-title":"Aging"},{"issue":"18","key":"7765_CR35","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1002\/cam4.4705","volume":"11","author":"XM Li","year":"2022","unstructured":"Li XM, Min ZX. The immune modulation effects of gemcitabine plus cisplatin induction chemotherapy in nasopharyngeal Carcinoma[J]. Cancer Med. 2022;11(18):3437\u201344.","journal-title":"Cancer Med"},{"issue":"2","key":"7765_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.it.2013.10.010","volume":"35","author":"N Barber Glen","year":"2014","unstructured":"Barber Glen N. STING-Dependent cytosolic DNA sensing Pathways[J]. Trends Immunol. 2014;35(2):88\u201393.","journal-title":"Trends Immunol"},{"issue":"7","key":"7765_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41389-020-00248-0","volume":"9","author":"C Zhang","year":"2020","unstructured":"Zhang C, Xia HD, Jia B, Valentin, et al. Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING Degradation[J]. Oncogenesis. 2020;9(7):65.","journal-title":"Oncogenesis"},{"key":"7765_CR38","doi-asserted-by":"crossref","unstructured":"Lv Yu Z, Jiahui G, Sichen et al. The AXL-Mediated modulation of Myeloid-Derived suppressor cells (MDSC) in nasopharyngeal Carcinoma[J]. Medical Oncology (Northwood, London, England), 2024, 42(1): 17.","DOI":"10.1007\/s12032-024-02561-9"},{"issue":"1","key":"7765_CR39","doi-asserted-by":"publisher","first-page":"288","DOI":"10.7150\/jca.101420","volume":"16","author":"B Li Haiyu","year":"2025","unstructured":"Li Haiyu B, Yanjie X, Zhikai, et al. The cellular signaling crosstalk between memory B cells and tumor cells in nasopharyngeal carcinoma cannot be overlooked: their involvement in tumor progression and treatment strategy is Significant[J]. J Cancer. 2025;16(1):288\u2013314.","journal-title":"J Cancer"},{"issue":"2","key":"7765_CR40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1182\/blood.2020008640","volume":"137","author":"S Debottam","year":"2021","unstructured":"Debottam S. Khanna Rajiv. EBV and Myeloid-Derived suppressor Cells[J]. Blood. 2021;137(2):148\u201350.","journal-title":"Blood"},{"issue":"2","key":"7765_CR41","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ni.3323","volume":"17","author":"J Murray Peter","year":"2016","unstructured":"Murray Peter J. Amino acid auxotrophy as a system of immunological control Nodes[J]. Nat Immunol. 2016;17(2):132\u20139.","journal-title":"Nat Immunol"},{"issue":"2","key":"7765_CR42","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1172\/JCI122085","volume":"129","author":"B-I Veronika","year":"2019","unstructured":"Veronika B-I, Bui Triet M, Wiesolek Hannah L, et al. Neutrophil-Induced genomic instability impedes resolution of inflammation and wound Healing[J]. J Clin Investig. 2019;129(2):712\u201326.","journal-title":"J Clin Investig"},{"key":"7765_CR43","doi-asserted-by":"crossref","unstructured":"An Xiaoqin Y, Wenfeng L. Jinbao, et al. Oxidative cell death in cancer: mechanisms and therapeutic Opportunities[J]. Volume 15. Cell Death & Disease; 2024. p. 556. 8.","DOI":"10.1038\/s41419-024-06939-5"},{"issue":"1","key":"7765_CR44","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/0008-8749(88)90258-4","volume":"114","author":"AK Lichtenstein","year":"1988","unstructured":"Lichtenstein AK, Ganz T, Selsted ME, et al. Synergistic cytolysis mediated by hydrogen peroxide combined with peptide Defensins[J]. Cell Immunol. 1988;114(1):104\u201316.","journal-title":"Cell Immunol"},{"issue":"5","key":"7765_CR45","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/ijc.28770","volume":"135","author":"B Mishalian Inbal","year":"2014","unstructured":"Mishalian Inbal B, Rachel E, Evgeniy, et al. Neutrophils recruit regulatory T-Cells into tumors via secretion of CCL17\u2013a new mechanism of impaired antitumor Immunity[J]. Int J Cancer. 2014;135(5):1178\u201386.","journal-title":"Int J Cancer"},{"key":"7765_CR46","doi-asserted-by":"crossref","unstructured":"Ju Julia A, Thompson Keyata N, Annis David A et al. Tubulin-Based Microtentacles Aid in Heterotypic Clustering of Neutrophil-Differentiated HL-60 Cells and Breast Tumor Cells[J]. Advanced Science (Weinheim, Baden-Wurttemberg, Germany), 2025, 12(6): e2409260.","DOI":"10.1002\/advs.202409260"},{"issue":"7","key":"7765_CR47","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3390\/ijms17071072","volume":"17","author":"J Koymans Kirsten","year":"2016","unstructured":"Koymans Kirsten J, Bisschop Adinda, Vughs Mignon M, et al. Staphylococcal Superantigen-like protein 1 and 5 (SSL1 & SSL5) limit neutrophil chemotaxis and migration through MMP-Inhibition[J]. Int J Mol Sci. 2016;17(7):1072.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"7765_CR48","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3390\/cancers17030384","volume":"17","author":"L Lu Tong","year":"2025","unstructured":"Lu Tong L. Neutrophil engulfment in cancer: friend or Foe?[J]. Cancers. 2025;17(3):384.","journal-title":"Cancers"},{"key":"7765_CR49","doi-asserted-by":"crossref","unstructured":"Brinkmann Volker R, Ulrike G, Christian et al. Neutrophil Extracellular Traps Kill Bacteria[J]. Science (New York, N.Y.), 2004, 303(5663): 1532\u20131535.","DOI":"10.1126\/science.1092385"},{"issue":"1","key":"7765_CR50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40364-025-00731-z","volume":"13","author":"D Liu Zhanrui","year":"2025","unstructured":"Liu Zhanrui D, Yuanyao L, Conghua, et al. Neutrophil extracellular traps in tumor metabolism and Microenvironment[J]. Biomark Res. 2025;13(1):12.","journal-title":"Biomark Res"},{"issue":"5","key":"7765_CR51","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/SLA.0000000000006196","volume":"279","author":"J Philippa","year":"2024","unstructured":"Philippa J, Devesh K. Beaumont Wilson Robert. NETosis in surgery: Pathophysiology, Prevention, and Treatment[J]. Ann Surg. 2024;279(5):765\u201380.","journal-title":"Ann Surg"},{"key":"7765_CR52","doi-asserted-by":"crossref","unstructured":"Wei WLTL, Jiunn LK et al. Mesenchymal Stromal\/Stem cells know best: the remarkable complexities of its interactions with polymorphonuclear Neutrophils[J]. Stem Cells (Dayton, Ohio), 2024, 42(5): 403\u201315.","DOI":"10.1093\/stmcls\/sxae011"},{"issue":"10","key":"7765_CR53","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1158\/0008-5472.CAN-23-2986","volume":"84","author":"Z Song Mengjia","year":"2024","unstructured":"Song Mengjia Z, Chaoqi C, Shaoyan, et al. DNA of neutrophil extracellular traps binds TMCO6 to impair CD8\u2009+\u2009T-Cell immunity in hepatocellular Carcinoma[J]. Cancer Res. 2024;84(10):1613\u201329.","journal-title":"Cancer Res"},{"issue":"10","key":"7765_CR54","doi-asserted-by":"publisher","first-page":"15208","DOI":"10.1021\/acsami.5c00670","volume":"17","author":"L Zhu Chenxu","year":"2025","unstructured":"Zhu Chenxu L, Chuang D, Yibo, et al. Precise oligopeptides block CCDC25 interaction with DNA in neutrophil extracellular traps inhibiting tumor Metastasis[J]. ACS Appl Mater Interfaces. 2025;17(10):15208\u201319.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"7765_CR55","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ccell.2024.12.004","volume":"43","author":"KS Lee WonJae","year":"2025","unstructured":"Lee WonJae KS, Yi A, Hironari, et al. Neutrophil extracellular traps promote Pre-Metastatic niche formation in the omentum by expanding Innate-like B cells that express IL-10[J]. Cancer Cell. 2025;43(1):69\u2013e8511.","journal-title":"Cancer Cell"},{"issue":"2","key":"7765_CR56","doi-asserted-by":"publisher","first-page":"114191","DOI":"10.1016\/j.yexcr.2024.114191","volume":"441","author":"G Guan Xiaoying","year":"2024","unstructured":"Guan Xiaoying G, Xiaoli Z, Zhiqiang, et al. NETs: important players in cancer progression and therapeutic Resistance[J]. Exp Cell Res. 2024;441(2):114191.","journal-title":"Exp Cell Res"},{"key":"7765_CR57","volume-title":"Neutrophil extracellular traps promote tumor chemoresistance to Anthracyclines[J]","author":"E Lin Cindy, Herlihy Sarah","year":"2024","unstructured":"Lin Cindy, Herlihy Sarah E, Li M, et al. Neutrophil extracellular traps promote tumor chemoresistance to Anthracyclines[J]. bioRxiv: The Preprint Server for Biology; 2024. 2024.11.7.622533."},{"issue":"22","key":"7765_CR58","doi-asserted-by":"publisher","first-page":"16274","DOI":"10.3390\/ijms242216274","volume":"24","author":"TS Jekle Andreas","year":"2023","unstructured":"Jekle Andreas TS, Kumar J, Ruchika, et al. Tumor regression upon intratumoral and subcutaneous dosing of the STING agonist ALG-031048 in mouse efficacy Models[J]. Int J Mol Sci. 2023;24(22):16274.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"7765_CR59","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1038\/s41418-019-0302-0","volume":"26","author":"C Zhang","year":"2019","unstructured":"Zhang C, Xia YS, Biao NJ. STING signaling remodels the tumor microenvironment by antagonizing Myeloid-Derived suppressor cell Expansion[J]. Cell Death Differ. 2019;26(11):2314\u201328.","journal-title":"Cell Death Differ"},{"key":"7765_CR60","doi-asserted-by":"crossref","unstructured":"Ye Maoyu H, Aijie Y, Bo, et al. European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology -. Head Neck Surg. 2024;281(4):1971\u201389. Neutrophil-to-Lymphocyte Ratio and Monocyte-to-Eosinophil Ratio as Prognostic Indicators for Advanced Nasopharyngeal Carcinoma[J].","DOI":"10.1007\/s00405-024-08474-7"},{"key":"7765_CR61","doi-asserted-by":"publisher","first-page":"107327482412881","DOI":"10.1177\/10732748241288106","volume":"31","author":"C Lv He","year":"2024","unstructured":"Lv He C, Xing C. High expression of NLR and SII in patients with nasopharyngeal carcinoma as potential prognostic Observations[J]. Cancer Control: J Moffitt Cancer Cent. 2024;31:10732748241288106.","journal-title":"Cancer Control: J Moffitt Cancer Cent"},{"issue":"11","key":"7765_CR62","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.jfma.2023.05.003","volume":"122","author":"LYFWC Yun","year":"2023","unstructured":"Yun LYFWC, Chia LW, et al. Postchemoradiotherapy systemic inflammation response index predicts treatment response and overall survival for patients with locally advanced nasopharyngeal Cancer[J]. J Formos Med Association = Taiwan Yi Zhi. 2023;122(11):1141\u20139.","journal-title":"J Formos Med Association = Taiwan Yi Zhi"},{"key":"7765_CR63","doi-asserted-by":"publisher","first-page":"575417","DOI":"10.3389\/fonc.2020.575417","volume":"10","author":"Z Feng Yuhua","year":"2020","unstructured":"Feng Yuhua Z, Na W, Sisi, et al. Systemic inflammation response index is a predictor of poor survival in locally advanced nasopharyngeal carcinoma: A propensity score matching Study[J]. Front Oncol. 2020;10:575417.","journal-title":"Front Oncol"},{"key":"7765_CR64","doi-asserted-by":"crossref","unstructured":"Chen Yuan J, Wenjie X, Dan et al. Development and Validation of Nomogram Based on SIRI for Predicting the Clinical Outcome in Patients with Nasopharyngeal Carcinomas[J]. Journal of Investigative Medicine: The Official Publication of the American Federation for Clinical Research, 2019, 67(3): 691\u2013698.","DOI":"10.1136\/jim-2018-000801"},{"issue":"6","key":"7765_CR65","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3892\/ol.2024.14385","volume":"27","author":"S Zhen","year":"2024","unstructured":"Zhen S, Jie T. Pan-Immune-Inflammation value as a novel prognostic biomarker in nasopharyngeal Carcinoma[J]. Oncol Lett. 2024;27(6):252.","journal-title":"Oncol Lett"},{"issue":"2","key":"7765_CR66","doi-asserted-by":"publisher","first-page":"2280002","DOI":"10.1080\/07853890.2023.2280002","volume":"55","author":"C Cao Jiaxin","year":"2023","unstructured":"Cao Jiaxin C, Qun B, Xue, et al. Predictive value of Immunotherapy-Induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint Inhibitors[J]. Ann Med. 2023;55(2):2280002.","journal-title":"Ann Med"},{"issue":"39","key":"7765_CR67","doi-asserted-by":"publisher","first-page":"66075","DOI":"10.18632\/oncotarget.19796","volume":"8","author":"C Jiang Wenjie","year":"2017","unstructured":"Jiang Wenjie C, Yuan H, Jin, et al. Systemic Immune-Inflammation index predicts the clinical outcome in patients with nasopharyngeal carcinoma: A propensity Score-Matched Analysis[J]. Oncotarget. 2017;8(39):66075\u201386.","journal-title":"Oncotarget"},{"issue":"1","key":"7765_CR68","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s13643-022-02123-y","volume":"11","author":"X Zeng Zesheng","year":"2022","unstructured":"Zeng Zesheng X, Shengen W, Dingting, et al. Prognostic significance of systemic Immune-Inflammation index in patients with nasopharyngeal carcinoma: A Meta-Analysis[J]. Syst Reviews. 2022;11(1):247.","journal-title":"Syst Reviews"},{"issue":"1","key":"7765_CR69","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/03936155231223198","volume":"39","author":"Y Somay Efsun","year":"2024","unstructured":"Somay Efsun Y, Busra T, Erkan, et al. Worth of Pan-Immune-Inflammation value in trismus prediction after concurrent chemoradiotherapy for nasopharyngeal Carcinomas[J]. Int J Biol Mark. 2024;39(1):80\u20138.","journal-title":"Int J Biol Mark"},{"issue":"7","key":"7765_CR70","doi-asserted-by":"publisher","first-page":"e7135","DOI":"10.1002\/cam4.7135","volume":"13","author":"L Lai Jing","year":"2024","unstructured":"Lai Jing L, Peixin Z, Jiafeng, et al. Development and internal validation of a nomogram based on peripheral blood inflammatory markers for predicting prognosis in nasopharyngeal Carcinoma[J]. Cancer Med. 2024;13(7):e7135.","journal-title":"Cancer Med"},{"key":"7765_CR71","doi-asserted-by":"crossref","unstructured":"Liao LJ, Hsu WL, Wang CT, et al. Prognostic impact of Pre-Treatment Neutrophil-to-Lymphocyte ratio (NLR) in nasopharyngeal carcinoma: A retrospective study of 180 Taiwanese Patients[J]. Clinical otolaryngology: official journal of ENT-UK; official journal of Netherlands. Volume 43. Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery; 2018. pp. 463\u20139. 2.","DOI":"10.1111\/coa.12992"},{"key":"7765_CR72","doi-asserted-by":"crossref","unstructured":"Ou Dan, Wang Xiaoshen, Wu Mingyao, et al. Prognostic Value of Post-Radiotherapy Neutrophil-to-Lymphocyte Ratio in Locally Advanced Nasopharyngeal Carcinoma[J]. Strahlentherapie Und Onkologie:Organ Der Deutschen Rontgengesellschaft \u2026 et Al], 2020, 196(3): 252\u2013261.","DOI":"10.1007\/s00066-019-01529-3"},{"issue":"2","key":"7765_CR73","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s13277-010-0124-7","volume":"32","author":"DP An Xin","year":"2011","unstructured":"An Xin DP, Rong W, Hua F, et al. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal Carcinoma[J]. Tumour Biology: J Int Soc Oncodevelopmental Biology Med. 2011;32(2):317\u201324.","journal-title":"Tumour Biology: J Int Soc Oncodevelopmental Biology Med"},{"issue":"6","key":"7765_CR74","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s00262-021-03075-3","volume":"71","author":"D Nickles Emily","year":"2022","unstructured":"Nickles Emily D, Bhushan Y, Li, et al. Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical Benefit[J]. Cancer Immunol Immunotherapy: CII. 2022;71(6):1531\u201343.","journal-title":"Cancer Immunol Immunotherapy: CII"},{"issue":"1","key":"7765_CR75","doi-asserted-by":"publisher","first-page":"9898","DOI":"10.1038\/s41598-024-59131-2","volume":"14","author":"L Yang Dong","year":"2024","unstructured":"Yang Dong L, Pian M, Zhen, et al. Combined pretreatment Neutrophil-Lymphocyte ratio and Platelet-Lymphocyte ratio predicts survival and prognosis in patients with Non-Metastatic nasopharyngeal carcinoma: A retrospective Study[J]. Sci Rep. 2024;14(1):9898.","journal-title":"Sci Rep"},{"key":"7765_CR76","doi-asserted-by":"crossref","unstructured":"Wei S, Linli Z, Min L, et al. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: Neutrophil-Lymphocyte ratio and Platelet-Lymphocyte ratio[J]. Volume 38. Head & Neck; 2016. pp. E1332\u20131340. Suppl 1.","DOI":"10.1002\/hed.24224"},{"key":"7765_CR77","doi-asserted-by":"crossref","unstructured":"Lu Aiying L, Haifeng Z, Yuming et al. Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma[J]. BioMed Research International, 2017, 2017: 3047802.","DOI":"10.1155\/2017\/3047802"},{"key":"7765_CR78","doi-asserted-by":"crossref","unstructured":"Zhang Junkai F, Weineng Y, Zhihua et al. Prognostic significance of Platelet-to-Lymphocyte ratio in patients with nasopharyngeal carcinoma: A Meta-Analysis[J]. Future Oncology (London, England), 2020, 16(5): 117\u201327.","DOI":"10.2217\/fon-2019-0520"},{"key":"7765_CR79","unstructured":"Lulu Y, Wihal OR, Fangfang K, et al. Prognostic values of hematological biomarkers in nasopharyngeal carcinoma patients treated with Intensity-Modulated Radiotherapy[J]. European archives of oto-rhino-laryngology: official journal of the European federation of Oto-Rhino-Laryngological societies (EUFOS): affiliated with the German society for Oto-Rhino-Laryngology -. Head Neck Surg. 2018;275(5):1309\u201317."},{"issue":"11","key":"7765_CR80","doi-asserted-by":"publisher","first-page":"9992","DOI":"10.18632\/oncotarget.24173","volume":"9","author":"Q Jiang Yanming","year":"2018","unstructured":"Jiang Yanming Q, Song P, Xinbin, et al. Prognostic value of Neutrophil-to-Lymphocyte ratio and Platelet-to-Lymphocyte ratio in intensity modulated radiation therapy for nasopharyngeal Carcinoma[J]. Oncotarget. 2018;9(11):9992\u201310004.","journal-title":"Oncotarget"},{"key":"7765_CR81","doi-asserted-by":"crossref","unstructured":"Chang H, Gao J, Xu BQ et al. Haemoglobin, neutrophil to lymphocyte ratio and platelet count improve prognosis prediction of the TNM staging system in nasopharyngeal carcinoma: development and validation in 3,237 patients from a single Institution[J]. Clinical Oncology (Royal College of Radiologists (Great Britain)), 2013, 25(11): 639\u201346.","DOI":"10.1016\/j.clon.2013.07.004"},{"issue":"5","key":"7765_CR82","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/lio2.660","volume":"6","author":"WY Li Jing","year":"2021","unstructured":"Li Jing WY, Ling L, Fei W, et al. Neutrophil to Apolipoprotein A-I ratio as an independent indicator of locally advanced nasopharyngeal Carcinoma[J]. Laryngoscope Invest Otolaryngol. 2021;6(5):1049\u201361.","journal-title":"Laryngoscope Invest Otolaryngol"},{"issue":"1","key":"7765_CR83","doi-asserted-by":"publisher","first-page":"e40881","DOI":"10.1016\/j.heliyon.2024.e40881","volume":"11","author":"H Xin","year":"2025","unstructured":"Xin H, Di WM, Qiong NW, et al. Development and validation of a prognostic nomogram incorporating Neutrophil-to-Albumin ratio for predicting overall survival in patients with nasopharyngeal carcinoma undergoing concurrent Chemoradiotherapy[J]. Heliyon. 2025;11(1):e40881.","journal-title":"Heliyon"},{"issue":"1","key":"7765_CR84","doi-asserted-by":"publisher","first-page":"5388","DOI":"10.1038\/s41598-024-56043-z","volume":"14","author":"C Zhang Sujuan","year":"2024","unstructured":"Zhang Sujuan C, Zui L, Jie, et al. Nomograms based on the Lymphocyte-Albumin-Neutrophil ratio (LANR) for predicting the prognosis of nasopharyngeal carcinoma patients after definitive Radiotherapy[J]. Sci Rep. 2024;14(1):5388.","journal-title":"Sci Rep"},{"issue":"4","key":"7765_CR85","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3390\/jcm14041088","volume":"14","author":"J-P Szeremeta Anna","year":"2025","unstructured":"Szeremeta Anna J-P, Agnieszka G, Alicja, et al. Changes in urinary NGAL, FN, and LN excretion in type 2 diabetic patients following Anti-Diabetic therapy with Metformin[J]. J Clin Med. 2025;14(4):1088.","journal-title":"J Clin Med"},{"key":"7765_CR86","doi-asserted-by":"publisher","first-page":"104797","DOI":"10.1016\/j.mvr.2025.104797","volume":"159","author":"Mayyas Fadia","year":"2025","unstructured":"Mayyas Fadia. Plasma neutrophil Gelatinase-Associated Lipocalin level as a predictor of atherosclerotic cardiovascular disease risk in patients undergoing Catheterization[J]. Microvasc Res. 2025;159:104797.","journal-title":"Microvasc Res"},{"issue":"2","key":"7765_CR87","doi-asserted-by":"publisher","first-page":"e70024","DOI":"10.1111\/jvim.70024","volume":"39","author":"B Dorn Elisabeth","year":"2025","unstructured":"Dorn Elisabeth B, Ann D, Nausikaa, et al. Outcome in critically ill dogs and dogs with acute kidney injury based on neutrophil Gelatinase-Associated Lipocalin and tissue inhibitor of Metalloproteinase-2[J]. J Vet Intern Med. 2025;39(2):e70024.","journal-title":"J Vet Intern Med"},{"issue":"2","key":"7765_CR88","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/biology14020161","volume":"14","author":"M Abdelrahman Aly","year":"2025","unstructured":"Abdelrahman Aly M, Al Raya M, Haytham A, et al. Effect of Riociguat on Adenine-Induced chronic kidney disease in Rats[J]. Biology. 2025;14(2):161.","journal-title":"Biology"},{"issue":"6","key":"7765_CR89","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/MEG.0000000000002935","volume":"37","author":"Y Fangran","year":"2025","unstructured":"Fangran Y, Zenghua Z, Xueke D, et al. Neutrophil Gelatinase-Associated Lipocalin for predicting acute kidney injury in orthotopic liver transplantation: A systematic review and Meta-Analysis[J]. Eur J Gastroenterol Hepatol. 2025;37(6):683\u201390.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"7765_CR90","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/s10157-025-02641-8","volume":"29","author":"K Inotani Satoshi","year":"2025","unstructured":"Inotani Satoshi K, Takeshi O, Yuki, et al. Efficacy of urinary [TIMP-2]\u22c5[IGFBP7], L-FABP, and NGAL levels for predicting Community-Acquired acute kidney injury in Japanese patients: A Single-Center, prospective cohort Study[J]. Clin Exp Nephrol. 2025;29(7):928\u201336.","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"7765_CR91","first-page":"3711","volume":"19","author":"Z Guo Ying","year":"2020","unstructured":"Guo Ying Z, Jianhua Z, Jing, et al. NGAL protects in nasopharyngeal carcinoma by inducing apoptosis and blocking Epithelial-Mesenchymal Transition[J]. Oncol Lett. 2020;19(6):3711\u20138.","journal-title":"Oncol Lett"},{"issue":"1","key":"7765_CR92","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13046-018-1003-0","volume":"38","author":"C Li Sen","year":"2019","unstructured":"Li Sen C, Xiliang G, Hongyu, et al. Tumor-Associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer Cells[J]. J Experimental Clin Cancer Research: CR. 2019;38(1):6.","journal-title":"J Experimental Clin Cancer Research: CR"},{"key":"7765_CR93","doi-asserted-by":"publisher","first-page":"689613","DOI":"10.3389\/fcell.2021.689613","volume":"9","author":"L Liu Xiaobei","year":"2021","unstructured":"Liu Xiaobei L, Tianxia M, Fei, et al. Antitumor and radiosensitization effects of a CXCR2 inhibitor in nasopharyngeal Carcinoma[J]. Front Cell Dev Biology. 2021;9:689613.","journal-title":"Front Cell Dev Biology"},{"issue":"2\u20133","key":"7765_CR94","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/cac2.12010","volume":"40","author":"W Zhang Wen","year":"2020","unstructured":"Zhang Wen W, Huishan S, Mingyang, et al. CXCL5\/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic Target[J]. Cancer Commun (London England). 2020;40(2\u20133):69\u201380.","journal-title":"Cancer Commun (London England)"},{"issue":"10","key":"7765_CR95","doi-asserted-by":"publisher","first-page":"S262","DOI":"10.1016\/j.jtho.2019.08.525","volume":"14","author":"M Meo","year":"2019","unstructured":"Meo M, De, Rayes R, Milette S, et al. Inhibition of CXCR2\u2009+\u2009Neutrophil migration as a targeted therapy in KRAS-Driven lung Adenocarcinoma[J]. J Thorac Oncol. 2019;14(10):S262\u20133.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"7765_CR96","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12935-022-02771-z","volume":"22","author":"H Tian Zhiqiang","year":"2022","unstructured":"Tian Zhiqiang H, Xiaojuan L, Wenting, et al. Targeted blocking of CCR2 and CXCR2 improves the efficacy of transarterial chemoembolization of Hepatocarcinoma[J]. Cancer Cell Int. 2022;22(1):362.","journal-title":"Cancer Cell Int"},{"issue":"6","key":"7765_CR97","doi-asserted-by":"publisher","first-page":"G773","DOI":"10.1152\/ajpgi.00080.2019","volume":"317","author":"M Konishi Takanori, Schuster Rebecca","year":"2019","unstructured":"Konishi Takanori, Schuster Rebecca M, Goetzman Holly S, et al. Cell-Specific regulatory effects of CXCR2 on cholestatic liver Injury[J]. Am J Physiol Gastrointest Liver Physiol. 2019;317(6):G773\u201383.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"8","key":"7765_CR98","doi-asserted-by":"publisher","first-page":"9583","DOI":"10.1007\/s00210-025-03970-x","volume":"398","author":"HM Sadique","year":"2025","unstructured":"Sadique HM, Ahsas G, Kavita G, et al. Targeting CXCR2 signaling in inflammatory lung diseases: Neutrophil-Driven inflammation and emerging Therapies[J]. Naunyn-Schmiedeberg\u2019s Archives Pharmacol. 2025;398(8):9583\u2013607.","journal-title":"Naunyn-Schmiedeberg\u2019s Archives Pharmacol"},{"issue":"2","key":"7765_CR99","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1053\/j.gastro.2024.02.046","volume":"167","author":"Z Xie Yongjie","year":"2024","unstructured":"Xie Yongjie Z, Tianxing L. Targeting ESE3\/EHF with Nifurtimox inhibits CXCR2\u2009+\u2009Neutrophil infiltration and overcomes pancreatic cancer resistance to chemotherapy and Immunotherapy[J]. Gastroenterology. 2024;167(2):281\u201397.","journal-title":"Gastroenterology"},{"issue":"11","key":"7765_CR100","doi-asserted-by":"publisher","first-page":"247","DOI":"10.21037\/atm.2019.04.73","volume":"7","author":"W Qingqing","year":"2019","unstructured":"Qingqing W, Bijie H. Successful therapy for autoimmune myocarditis with pembrolizumab treatment for nasopharyngeal Carcinoma[J]. Annals Translational Med. 2019;7(11):247.","journal-title":"Annals Translational Med"},{"issue":"3","key":"7765_CR101","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jaccao.2020.08.001","volume":"2","author":"A Aras Mandar","year":"2020","unstructured":"Aras Mandar A, Power John R, Moslehi Javid J. Inflammatory biomarkers to detect immune checkpoint Inhibitor-Associated cardiotoxicity in lung cancer patients: ready for prime Time?[J]. JACC CardioOncology. 2020;2(3):503\u20135.","journal-title":"JACC CardioOncology"},{"key":"7765_CR102","doi-asserted-by":"publisher","first-page":"104935","DOI":"10.1016\/j.oraloncology.2020.104935","volume":"108","author":"PJ Chul","year":"2020","unstructured":"Chul PJ, Julia D, Karim B, et al. The efficacy of Anti-PD-1 immune checkpoint inhibitor in nasopharyngeal Carcinoma[J]. Oral Oncol. 2020;108:104935.","journal-title":"Oral Oncol"},{"issue":"12","key":"7765_CR103","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/emmm.201201569","volume":"4","author":"L Chen","year":"2012","unstructured":"Chen L, Chyang WL, Jie TN, Ming, et al. Tumour Inflammasome-Derived IL-1\u03b2 recruits neutrophils and improves local Recurrence-Free survival in EBV-Induced nasopharyngeal Carcinoma[J]. EMBO Mol Med. 2012;4(12):1276\u201393.","journal-title":"EMBO Mol Med"},{"key":"7765_CR104","doi-asserted-by":"crossref","unstructured":"Qu Mengdi Z, Chenyu S, Caihong et al. Neutrophil Extracellular Traps Promote Pancreatic Cancer Progression via the STING Pathway[J]. Gastroenterology Research and Practice, 2025, 2025: 4950214.","DOI":"10.1155\/grp\/4950214"},{"key":"7765_CR105","doi-asserted-by":"crossref","unstructured":"Yue C, Haoyue H, Songtao T, et al. The role of neutrophil extracellular traps in cancer Progression, metastasis and Therapy[J]. Volume 11. Experimental Hematology & Oncology; 2022. p. 99. 1.","DOI":"10.1186\/s40164-022-00345-3"},{"key":"7765_CR106","doi-asserted-by":"crossref","unstructured":"Skov Lone, Beurskens Frank J, Zachariae Claus OC et al. IL-8 as Antibody Therapeutic Target in Inflammatory Diseases: Reduction of Clinical Activity in Palmoplantar Pustulosis[J]. Journal of Immunology (Baltimore, Md.: 1950), 2008, 181(1): 669\u2013679.","DOI":"10.4049\/jimmunol.181.1.669"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07765-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07765-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07765-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:03:34Z","timestamp":1774620214000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07765-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7765"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07765-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"428"}}